Pfizer Independent Medical Education Grant Request for Proposals: New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) 2026

Oncology Information for Grant Submissions

Bayer funds educational programs advancing knowledge of new therapies, treatment strategies, and quality of life in advanced prostate cancer.

BayerRolling submissions

Advanced Prostate – Call For Grant (1) - SUO

Bayer funds educational initiatives advancing clinical knowledge and care in advanced prostate cancer, focusing on recent research, evidence gaps, and survivorship using innovative formats.

BayerRolling submissions

Advanced Prostate – Call For Grant (2) - Optimizing Treatment Outcomes in mCSPC; Evolving Evidence and Clinical Trial Design

Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).

BayerRolling submissions

Advanced Prostate – Call For Grant (3) – Quality of life and patient‑centered care in advanced prostate cancer

Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.

BayerRolling submissions

Pfizer Research and Quality Improvement Grant Request for Proposals

Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.

PfizerDue Nov 15, 2026$50,000